| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |